SUVPFOTC Markets OTCPK
Sartorius Aktiengesellschaft
$288.22
ListedJul 30, 2014
SectorHealthcare
IndustryMedical Instruments & Supplies
CountryGermany
Employees14242
State-| CityGöttingen| AddressOtto-Brenner-Strasse 20| Phone49 551 308 0
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
85.4
?
Div. Rate
$0.85
?
Div. Yield
0.31%
?
Payout Ratio
31.49%
?
Max Consec. Div. Years
8 years
?
Longest Consec. Div.
8 years
?
Div. Coverage
91%
?
Div. Stability Rate
0.35
?
Div. Growth Rate
50.00%
?
Score
72

Dividend History

Historical dividend payments by ex-dividend date.

Mar 27, 2026
$ 0.8606
Mar 28, 2025
$ 0.8606
Apr 2, 2024
$ 0.8606
Mar 30, 2023
$ 1.6746
Mar 28, 2022
$ 1.4653
Mar 29, 2021
$ 0.8257
Jun 29, 2020
$ 0.4187
Mar 29, 2019
$ 0.7210
Apr 6, 2018
$ 0.5931
Apr 8, 2016
$ 0.4419
Apr 10, 2015
$ 0.3140

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!